tag:blogger.com,1999:blog-2546008714740235720.post3917815106708873466..comments2024-03-29T10:10:59.900+00:00Comments on The ChEMBL-og: New Drug Approvals - Pt. XX - Pazopanib (Votrient)Unknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-2546008714740235720.post-87551024326699287492011-09-09T08:08:51.902+01:002011-09-09T08:08:51.902+01:00Pazopanib (brand name Votrient) is a powerful and ...<a href="http://yellowtogreen.blogspot.com/2011/09/pazopanib-renal-cell-carcinoma-drugs.html" rel="nofollow">Pazopanib</a> (brand name Votrient) is a powerful and selective multi targeted sensory receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a, and c-kit that blockings tumor development and reduces angiogenesis.coolfx89https://www.blogger.com/profile/13827149267777950001noreply@blogger.com